EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for BCYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -2.731
March 31, 2026 -3.163
December 31, 2025 -3.173
September 30, 2025 -3.627
June 30, 2025 -3.524
March 31, 2025 -3.136
December 31, 2024 -2.878
September 30, 2024 -3.302
June 30, 2024 -3.811
March 31, 2024 -4.460
December 31, 2023 -5.150
September 30, 2023 -5.000
June 30, 2023 -4.693
March 31, 2023 -4.174
December 31, 2022 -3.786
September 30, 2022 -3.380
June 30, 2022 -3.017
March 31, 2022 -2.863
Date Value
December 31, 2021 -2.672
September 30, 2021 -2.897
June 30, 2021 -2.844
March 31, 2021 -2.773
December 31, 2020 -2.668
September 30, 2020 -2.082
June 30, 2020 -2.077
March 31, 2020 -2.798
December 31, 2019 -2.663
September 30, 2019 -2.860
June 30, 2019 -2.764
March 31, 2019 -1.649
December 31, 2018 -1.299
September 30, 2018 -1.214
June 30, 2018 -0.7838
March 31, 2018 -0.5059
December 31, 2017 -0.3618

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Autolus Therapeutics Plc -1.050
Akari Therapeutics Plc -19.78
Biodexa Pharmaceuticals Plc -103.95
DBV Technologies SA -3.514
Cellectis SA -0.6502